Relationship between the mucosal production of reactive oxygen radicals and density of Helicobacter pylori in patients with duodenal ulcer

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 3, 1997, Pages 261-265

  Zhang, Qibo ^a   Dawodu, Jaiye B ^a   Etolhi, Giamal ^a   Husain, Akhtar ^a   Gemmell, Curtis G ^a   Russell, Robin I ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Duodenal ulcer; Helicobacter pylori density; Reactive oxygen radicals

Indexed keywords

OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; COLONY FORMING UNIT; DUODENUM BIOPSY; DUODENUM MUCOSA; DUODENUM ULCER; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH BIOPSY;

EID: 0030957640     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199703000-00008     Document Type: Article

References (34)

1. Nielsen H, Andersen LP: Activation of human phagocyte oxidative metabolism by Helicobacter pylori. Gastroenterology 1992, 103:1747-1753.
2. Mai UEH, Perez-Perez GI, Wahl LM, et al.: Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest 1991, 87:894-900.
3. Mooney C, Keenan J, Munster D, et al.: Neutrophil activation by Helicobacter pylori. Gut 1991, 32:853-857.
4. Zhang QB, Nakshabendi JM, Mokhashi MS, et al.: Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut 1996, 38:841-845.
5. Winrow VR, Winyard PC, Morris CJ, et al.: Free radicals in inflammation: second messengers and mediators of tissue destruction. Br Med Bull 1993, 49:506-522.
6. Szelenyil, Brume K: Possible role of oxygen radicals in ethanol-induced gastric mucosal damage in rats. Dig Dis Sci 1988, 33:865-871.
7. Davies GR, Simmonds NJ, Stevens TRJ, et al.: Helicobacter pylori stimulates antral mucosal reactive oxygen metabolites production in vivo. Gut 1994, 35:179-185.
8. Davies GR, Simmonds NJ, Stevens TRJ, et al.: Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 1992, 33:1467-1472.
9. Gormally SM, Kierce BM, Daly LE, et al.: Gastric metaplasia and duodenal ulcer disease in children infected by Helicobacter pylori. Gut 1996, 38:513-517.
10. Wyatt JI, Rathbone BJ, Sobala GM, et al.: Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol 1990, 43:981-986.
11. Wyatt JI, Rathbone BJ, Dixon MF, et al.: Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987, 40:841-848.
12. Yang H, Dixon MF, Zuo J, et al.: Helicobacter pylori infection and gastric metaplasia in the duodenum in China. J Clin Gastroenterol 1995, 20:110-112.
13. Khulusi S, Mendal MA, Badve S, et al.: Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum. Gut 1995, 36:193-197.
14. Khulusi S, Mendall MA, Patel P, et al.: Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects. Gut 1995, 37:319-324.
15. Burnett RA, Brown IL, Findlay J: Cresyl fast violet staining method for Campylobacter like organisms. J Clin Pathol 1987, 40:353.
16. Cover TL, Puryear W, Perez-Perez GI, et al.: Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun 1991, 59:1264-1270.
17. Davies GR, Banatvala N, Collins CE, et al.: Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 1994, 29:419-424.
18. Reutelin H, Blomberg B, Fredlund H, et al.: Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut 1993, 34:599-603.
19. Reutelin H, Blomberg B, Jarnerot G, et al.: Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcerogenic markers. Scand J Gastroenterol 1994, 29:128-132.
20. Graham DY: Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989, 96:615-625.
21. Tytgat GN, Noach L, Rauws EA: Helicobacter pylori. Scand J Gastroenterol 1991, 187(suppl.):1-8.
22. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease: Helicobacter pylori in peptic ulcer disease. JAMA 1994, 272:66-69.
23. Blaser MJ: Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990, 161:626-633.
24. Rauws EA, Tytgat GN: Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990, 335:1233-1235.
25. George LL, Borody TJ, Andrews P, et al.: Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990, 153:145-149.
26. Graham DY, Lew GM, Klein PD, et al.: Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomised, controlled study. Ann Intern Med 1992, 116:705-708.
27. Marshall BJ, Warren JR, Goodvvin CS: Duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1989, ii:836-837.
28. Bell GD, Powell KU: Eradication of Helicobacter pylori and its effect in peptic ulcer disease. Scand J Gastroenterol 1993, 28(suppl. 196):7-11.
29. Forbes GM, Glaser ME, Cullen DJE: Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994, 343:258-260.
30. Xiang Z, Censini S, Bayeli PF, et al.: Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that the clinical isolates can be divided into two major types and that CagA is not necessary for the expression of the vacuolating toxin. Infect Immun 1995, 63:94-98.
31. Figura N, Guglielmetti P, Rossolini A, et al.: Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989, 27:225-226.
32. Leunk RD, Johnson PT, David BC, et al.: Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988, 26:93-99.
33. Crabtree JE, Taylor JD, Wyatt JI, et al.: Mucosal IgA recognition of Helicobacter pylori 120KDa protein, peptic ulceration and gastric pathology. Lancet 1991, 338:332-335
34. Crabtree JE, Figura N, Taylor JD, et al.: Expression of 120 kilodalton protein and cytotoxicity in Helicobacter pylori. J Clin Pathol 1992, 45:733-734.